210 related articles for article (PubMed ID: 35740558)
1. Localized Small Bowel Adenocarcinoma Management: Evidence Summary.
Turpin A; El Amrani M; Zaanan A
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740558
[TBL] [Abstract][Full Text] [Related]
2. Clinical Outcomes of Small Bowel Adenocarcinoma.
Akce M; Jiang R; Zakka K; Wu C; Alese OB; Shaib WL; Behera M; El-Rayes BF
Clin Colorectal Cancer; 2019 Dec; 18(4):257-268. PubMed ID: 31606297
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Lymph Node Evaluation in Stage II Small Bowel Adenocarcinoma: An Updated Analysis of Surveillance, Epidemiology, and End Results Database.
Liu Z; Liu K; Gao J; Jing C; Ma Y; Zheng S; Shan J
Front Oncol; 2022; 12():865745. PubMed ID: 35402228
[TBL] [Abstract][Full Text] [Related]
4. Natural history and prognostic factors for localised small bowel adenocarcinoma.
Colina A; Hwang H; Wang H; Katz MHG; Sun R; Lee JE; Thomas J; Tzeng CW; Wolff RA; Raghav K; Overman MJ
ESMO Open; 2020 Nov; 5(6):e000960. PubMed ID: 33188051
[TBL] [Abstract][Full Text] [Related]
5. Management of small bowel adenocarcinoma: making the most of the available evidence to inform routine practice.
Mazlom H; Teuwen LA; Peeters M
Curr Opin Oncol; 2021 Jul; 33(4):368-371. PubMed ID: 33882527
[TBL] [Abstract][Full Text] [Related]
6. Characterization and Clinical Outcomes of DNA Mismatch Repair-deficient Small Bowel Adenocarcinoma.
Latham A; Shia J; Patel Z; Reidy-Lagunes DL; Segal NH; Yaeger R; Ganesh K; Connell L; Kemeny NE; Kelsen DP; Hechtman JF; Nash GM; Paty PB; Zehir A; Tkachuk KA; Sheikh R; Markowitz AJ; Mandelker D; Offit K; Berger MF; Cercek A; Garcia-Aguilar J; Saltz LB; Weiser MR; Stadler ZK
Clin Cancer Res; 2021 Mar; 27(5):1429-1437. PubMed ID: 33199489
[TBL] [Abstract][Full Text] [Related]
7. DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy.
Sinicrope FA; Foster NR; Thibodeau SN; Marsoni S; Monges G; Labianca R; Kim GP; Yothers G; Allegra C; Moore MJ; Gallinger S; Sargent DJ
J Natl Cancer Inst; 2011 Jun; 103(11):863-75. PubMed ID: 21597022
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
9. Small Bowel Adenocarcinoma: From Molecular Insights to Clinical Management.
Gelsomino F; Balsano R; De Lorenzo S; Garajová I
Curr Oncol; 2022 Feb; 29(2):1223-1236. PubMed ID: 35200603
[TBL] [Abstract][Full Text] [Related]
10. Prognosis of small bowel adenocarcinoma in Crohn's disease compares favourably with de novo small bowel adenocarcinoma.
Wieghard N; Mongoue-Tchokote S; Young JI; Sheppard BC; Tsikitis VL
Colorectal Dis; 2017 May; 19(5):446-455. PubMed ID: 27659145
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and treatment outcomes in patients with Small Bowel Adenocarcinoma (SBA): the Royal Marsden Hospital (RMH) experience.
Khan K; Peckitt C; Sclafani F; Watkins D; Rao S; Starling N; Jain V; Trivedi S; Stanway S; Cunningham D; Chau I
BMC Cancer; 2015 Jan; 15():15. PubMed ID: 25603878
[TBL] [Abstract][Full Text] [Related]
12. Clinical features, treatment, and prognosis of different histological types of primary small bowel adenocarcinoma: A propensity score matching analysis based on the SEER database.
Zhou YW; Xia RL; Chen YY; Ma XL; Liu JY
Eur J Surg Oncol; 2021 Aug; 47(8):2108-2118. PubMed ID: 33849741
[TBL] [Abstract][Full Text] [Related]
13. Metastasis Pattern and Survival Analysis in Primary Small Bowel Adenocarcinoma: A SEER-Based Study.
Gu Y; Deng H; Wang D; Li Y
Front Surg; 2021; 8():759162. PubMed ID: 34950695
[No Abstract] [Full Text] [Related]
14. Meta-analysis of postoperative adjuvant therapy for small bowel adenocarcinoma.
Ye X; Zhang G; Chen H; Li Y
PLoS One; 2018; 13(8):e0200204. PubMed ID: 30096150
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma.
Overman MJ; Kopetz S; Wen S; Hoff PM; Fogelman D; Morris J; Abbruzzese JL; Ajani JA; Wolff RA
Cancer; 2008 Oct; 113(8):2038-45. PubMed ID: 18759326
[TBL] [Abstract][Full Text] [Related]
16. Small Bowel Adenocarcinoma: 10-Year Experience in a Cancer Center-The Ottawa Hospital (TOH).
Alfagih A; Alrehaili M; Asmis T
Curr Oncol; 2022 Oct; 29(10):7439-7449. PubMed ID: 36290862
[TBL] [Abstract][Full Text] [Related]
17. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
18. Metastatic small bowel adenocarcinoma: role of metastasectomy and systemic chemotherapy.
Bhamidipati D; Colina A; Hwang H; Wang H; Katz M; Fournier K; Serpas V; Thomas J; Sun R; Wolff RA; Raghav K; Overman MJ
ESMO Open; 2021 Jun; 6(3):100132. PubMed ID: 33940348
[TBL] [Abstract][Full Text] [Related]
19. Patterns of failure following surgical resection for malignant pleural mesothelioma.
Jänne PA; Baldini EH
Thorac Surg Clin; 2004 Nov; 14(4):567-73. PubMed ID: 15559064
[TBL] [Abstract][Full Text] [Related]
20. Association of DNA Mismatch Repair and Mutations in BRAF and KRAS With Survival After Recurrence in Stage III Colon Cancers : A Secondary Analysis of 2 Randomized Clinical Trials.
Sinicrope FA; Shi Q; Allegra CJ; Smyrk TC; Thibodeau SN; Goldberg RM; Meyers JP; Pogue-Geile KL; Yothers G; Sargent DJ; Alberts SR
JAMA Oncol; 2017 Apr; 3(4):472-480. PubMed ID: 28006055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
